ORMP - ORAMED PHARMACEUTICALS INC.
3.62
0.240 6.630%
Share volume: 163,978
Last Updated: 03-04-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.72%
PREVIOUS CLOSE
CHG
CHG%
$3.38
0.24
0.07%
Summary score
12%
Profitability
0%
Dept financing
9%
Liquidity
50%
Performance
15%
Sector
Manufacturing
Industry
Pharmaceutical Products/Pharmaceutical Preparations
Long-term ratios 30-Sep-2015 - 30-Sep-2019
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-14.55%
Return on assets
-8.13%
Return on sales
-617.32%
Return on invested capital
-33.01%
Total debt ratio
44.05%
Debt ratio change over timeo
0%
Current Ratio
5.67%
Quick Ratio
0%
Cash Position Ratio
0.67%
Short-term ratios 30-Sep-2018 - 30-Sep-2019
The data are presented for the financials results of the quarters of the last year.
Return on equity
-15.04%
Return on assets
-9.21%
Return on sales
-612.08%
Return on invested capital
-27.75%
Total debt ratio
39.91%
Debt ratio change over timeo
0%
Current Ratio
6.07%
Quick Ratio
0%
Cash Position Ratio
0.75%
Last quarter ratios 30-Sep-2019
The data are presented for the financials results of the last quarter.
Return on equity
-11.76%
Return on assets
-6.77%
Return on sales
0%
Return on invested capital
57.45%
Total debt ratio
44.05%
Debt ratio change over time
0%
Current Ratio
6.28%
Quick Ratio
0%
Cash Position Ratio
0.63%
Performance ratios (change over 4 years) 30-Sep-2015 - 30-Sep-2019
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
0%
Return on assets
0%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
0%
Debt ratio change over time
0%
Current Ratio
0%
Quick Ratio
0%
Cash Position Ratio
0%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | ORMP | LLY | JNJ | ABBV |
|---|---|---|---|---|
| Return on equity | -14.55% | 10.78% | 4.09% | 5.89% |
| Return on assets | -8.13% | 3.26% | 3.42% | 3.81% |
| Return on sales | -617.32% | 23.28% | 26.47% | 33.24% |
| Return on invested capital | -33.01% | 4.09% | 4.02% | 4.43% |
| Profitability | 0% | 87% | 75% | 89% |
| Total debt ratio | 44.05% | 73.53% | 56.89% | 99.62% |
| Debt ratio change over time | 0% | 0% | 8.85% | 96.02% |
| Dept financing | 11% | 18% | 17% | 50% |
| Current Ratio | 6.07% | 1.29% | 1.38% | 1.02% |
| Quick Ratio | 0% | 1% | 1.09% | 0.91% |
| Cash Position Ratio | 0.75% | 0.3% | 0.54% | 0.44% |
| Liquididy | 50% | 39% | 55% | 47% |
| Short-term ratios | ORMP | LLY | JNJ | ABBV |
|---|---|---|---|---|
| Return on equity | -15.04% | 29.72% | 5.92% | -10.21% |
| Return on assets | -9.21% | 3.64% | 3.4% | 3.12% |
| Return on sales | -612.08% | 25.5% | 25.5% | 21.95% |
| Return on invested capital | -27.75% | 8.1% | 4.48% | 3.21% |
| Profitability | 0% | 100% | 67% | 53% |
| Total debt ratio | 39.91% | 88.74% | 61.26% | 114.21% |
| Debt ratio change over time | 0% | 0% | 11.4% | 11.56% |
| Dept financing | 9% | 19% | 38% | 50% |
| Current Ratio | 6.07% | 1.29% | 1.38% | 1.02% |
| Quick Ratio | 0% | 1% | 1.09% | 0.91% |
| Cash Position Ratio | 0.75% | 0.3% | 0.54% | 0.44% |
| Liquididy | 50% | 38% | 49% | 40% |